Citation: Ld. Andress et Rj. Guttendorf, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR CI-1004, A DUAL-INHIBITOR ANTIINFLAMMATORY AGENT, IN RAT, RABBIT, DOG, MONKEY AND HUMAN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 698(1-2), 1997, pp. 171-179
Authors:
BARKSDALE CM
COON MJ
TURLUCK DA
GUTTENDORF RJ
NORDBLOM GD
Citation: Cm. Barksdale et al., PHARMACOKINETICS AND BIOAVAILABILITY OF CI-977 IN RATS AND DOGS, Journal of clinical ligand assay, 20(2), 1997, pp. 206-211
Citation: Kl. Hoffman et al., AUTOMATED-DETERMINATION OF A NOVEL ANTIINFLAMMATORY DRUG IN PLASMA USING BATCH ROBOTIC SAMPLE PREPARATION AND HPLC, Laboratory robotics and automation, 8(4), 1996, pp. 237-242
Authors:
PRASAD JVNV
TUMMINO PJ
FERGUSON D
SAUNDERS J
VANDERROEST S
MCQUADE TJ
HELDSINGER A
REYNER EL
STEWART BH
GUTTENDORF RJ
PARA KS
LUNNEY EA
GRACHECK SJ
DOMAGALA JM
Citation: Jvnv. Prasad et al., NONPEPTIDIC HIV PROTEASE INHIBITORS - 4-HYDROXY-PYRAN-2-ONE INHIBITORS WITH FUNCTIONAL TETHERS TO P-1 PHENYL RING TO REACH S-3 POCKET OF THE ENZYME, Biochemical and biophysical research communications, 221(3), 1996, pp. 815-820
Authors:
PRASAD JVNV
LUNNEY EA
FERGUSON D
TUMMINO PJ
RUBIN JR
REYNER EL
STEWART BH
GUTTENDORF RJ
DOMAGALA JM
SUVOROV LI
GULNIK SV
TOPOL IA
BHAT TN
ERICKSON JW
Citation: Jvnv. Prasad et al., HIV PROTEASE INHIBITORS POSSESSING A NOVEL, HIGH-AFFINITY, AND ACHIRAL P-1' P-2' LIGAND WITH A UNIQUE PATTERN OF IN-VITRO RESISTANCE - IMPORTANCE OF A CONFORMATIONALLY-RESTRICTED TEMPLATE IN THE DESIGN OF ENZYME-INHIBITORS/, Journal of the American Chemical Society, 117(45), 1995, pp. 11070-11074